Alzheimer's disease models and functional genomics-How many needles are there in the haystack?

Frontiers in Physiology

Volumn 3 AUG, Issue , 2012, Pages

  Götz, Jürgen ^a   Matamales, Miriam ^a   Götz, Naeman N ^a   Ittner, Lars M ^b   Eckert, Anne ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Alzheimer's disease; Amyloid; Frontotemporal dementia; Kinase; Phosphatase; Proteomic; Tau; Transcriptomic

Indexed keywords

EID: 84866484312     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00320     Document Type: Review

References (175)

1. Alavez, S., Vantipalli, M. C., Zucker, D.J., Klang, I. M., and Lithgow, G. J. (2011). Amyloid-binding com pounds maintain protein home-ostasis during ageing and extend lifespan. Nature 472, 226-229.
2. Al-Bassam, J., Ozer, R. S., Safer, D., Halpain, S., and Milligan, R. A. (2002). MAP2 and tau bind longitudinally along the outer ridges of microtubule protofilaments. J. Cell Biol. 157, 1187-1196.
3. Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N., and Murtagh, E R. (1995). An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin. Anat. 8, 429-431.
4. Avila, J. (2006). Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Lett. 580, 2922-2927
5. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E.(2011). Alzheimer's disease. Lancet 377, 1019-1031.
6. Bi, M., Ittner, A., Ke, Y. D., Gotz, J., and Ittner, L. M. (2011). Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice. PLoS ONE 6:e26860. doi: 10.1371/journal.pone.0026860
7. Blessed, G., Tomlinson, B. E., and Roth, M. (1968). The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 114, 797-811.
8. Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
9. Brandt, R., Gergou, A., Wacker, I., Fath, T., and Hutter, H. (2009). A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau. Neurobiol. Aging 30, 22-33.
10. Brion, J. P., Passareiro, H., Nunez, J., and Flament-Durand, D. (1985). Mise en évidence de la protéine Tau au niveau des lésions de dégénéres-cence neurofibrillaire de la maladie d'Alzheimer. Arch. Biol. (Bruxelles) 95, 229-235.
11. Cavallaro, S., D'Agata, V., Manickam, P., Dufour, F., and Alkon, D. L. (2002). Memory-specific temporal profiles of gene expression in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 99, 16279-16284.
12. Chartier-Harlin, M. C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., and Mullan, M. (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353, 844-846.
13. Chen, F., David, D., Ferrari, A., and Gotz, J. (2004a). Posttranslational modifications of tau-Role in human tauopathies and modeling in transgenic animals. Curr. Drug Targets 5, 503-515.
14. Chen, F., Wollmer, M. A., Hoerndli, F., Münch, G., Kuhla, B., Rogaev, E. I., Tsolaki, M., Papassotiropoulos, A., and Gotz, J. (2004b). Role for glyoxalase I in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 7687-7692.
15. Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., and Lukiw, W. J. (2002). Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1, transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462-473.
16. Cottrell, B. A., Galvan, V., Banwait, S., Gorostiza, O., Lombardo, C. R., Williams, T., Schilling, B., Peel, A., Gibson, B., Koo, E. H., Link, C. D., and Bredesen, D. E. (2005). A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease. Ann. Neurol. 58, 277-289.
17. Cynis, H., Scheel, E., Saido, T. C., Schilling, S., and Demuth, H. U. (2008). Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta. Biochemistry 47, 7405-7413.
18. David, D., Hoerndli, F., and Gotz, J. (2005a). Functional Genomics meets neurodegenerative disorders Part I: Transcriptomic and proteomic technology. Prog. Neurobiol. 76, 153-168.
19. David, D. C., Hauptmann, S., Scherping, I., Schuessel, K., Keil, U., Rizzu, P., Ravid, R., Dröse, S., Brandt, U., Müller, W E., Eckert, E., and Gotz, J. (2005b). Proteomic and functional analysis reveal a mito-chondrial dysfunction in P301L tau transgenic mice. J. Biol. Chem. 280, 23802-23814.
20. David, D. C., Ittner, L. M., Gehrig, P., Nergenau, D., Shepherd, C., Halliday, G., and Gotz, J. (2006). ß-Amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes. Proteomics 6, 6566-6577.
21. Dehmelt, L., and Halpain, S. (2005). The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 6,204.
22. Delacourte, A., and Defossez, A. (1986). Alzheimer's disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J. Neurol. Sci. 76, 173-186.
23. Deters, N., Ittner, L. M., and Gotz, J. (2008). Divergent phosphorylation pattern of tau in P301L tau transgenic mice. Eur. J. Neurosci. 28, 137-147.
24. Dieterich, D. C., Hodas, J. J., Gouzer, G., Shadrin, I. Y., Ngo, J. T., Triller, A., Tirrell, D. A., and Schuman, E. M. (2010). In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons. Nat. Neurosci. 13, 897-905.
25. Dieterich, D. C., Link, A. J., Graumann, J., Tirrell, D. A., and Schuman, E. M. (2006). Selective identification of newly synthesized proteins in mammalian cells using bioorthog-onal noncanonical amino acid tagging (BONCAT). Proc. Natl. Acad. Sci. U.S.A. 103, 9482-9487.
26. Dolan, P. J., and Johnson, G. V. (2010). The role of tau kinases in Alzheimer's disease. Curr. Opin. DrugDiscov. Devel. 13, 595-603.
27. Dormann, D., Capell, A., Carlson, A. M., Shankaran, S. S., Rodde, R., Neumann, M., Kremmer, E., Matsuwaki, T., Yamanouchi, K., Nishihara, M., and Haass, C. (2009). Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. J. Neurochem. 110, 1082-1094.
28. Dormann, D., and Haass, C. (2011). TDP-43 and FUS: a nuclear affair. Trends Neurosci. PMID: 21700347. [Epub ahead of print]
29. Dostal, V., Roberts, C. M., and Link, C.D. (2010). Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of beta-amyloid peptide toxicity. Genetics 186, 857-866.
30. Drake, J., Link, C. D., and Butterfield, D.A. (2003). Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging24, 415-420.
31. Eckert, A., Hauptmann, S., Scherping, I., Meinhardt, J., Rhein, V., Drose, S., Brandt, U., Fandrich, M., Muller, W. E., and Gotz, J. (2008). Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice. J. Mol. Med. 86, 1255-1267.
32. Eckert, A., Schmitt, K., and Gotz, J. (2011). Mitochondrial dysfunction-the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-beta toxicity. Alzheimers Res. Ther. 3, 15.
33. Eckert, A., Schulz, K. L., Rhein, V., and Gotz, J. (2010). Convergence of amyloid-beta and tau pathologies on mitochondria in vivo. Mol. Neurobiol. 41, 107-114.
34. Edbauer, D., Winkler, E., Regula, J. T., Pesold, B., Steiner, H., and Haass, C. (2003). Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486-488.
35. Fabian, M. R., Sonenberg, N., and Filipowicz, W. (2010). Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79,351-379.
36. Ferrari, A., Hoerndli, F., Baechi, T., Nitsch, R. M., and Gotz, J. (2003). Beta-amyloid induces PHF-like tau filaments in tissue culture. J. Biol. Chem. 278, 40162-40168.
37. Freude, S., Schilbach, K., and Schubert, M. (2009). The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease. Curr. Alzheimer Res. 6,213-223.
38. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., and Zhao, J. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein [see comments]. Nature 373, 523-527.
39. Gillardon, F., Rist, W., Kussmaul, L., Vogel, J., Berg, M., Danzer, K., Kraut, N., and Hengerer, B. (2007). Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics 7, 605-616.
40. Ginsberg, S. D., Hemby, S. E., Lee, V. M., Eberwine, J. H., and Trojanowski, J. Q. (2000). Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 48, 77-87.
41. Glenner, G. G., and Wong, C. W. (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
42. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, E, Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rossor, M., Owen, M., and Hardy, J. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
43. Goate, A., and Hardy, J. (2012). Twenty years of Alzheimer's disease-causing mutations. J. Neurochem. 120(Suppl. 1), 3-8.
44. Goate, A. M., Haynes, A. R., Owen, M. J., Farrall, M., James, L. A., Lai, L. Y., Mullan, M. J., Roques, P., Rossor, M. N., Williamson, R., and Hardy, J. A. (1989). Predisposing locus for Alzheimer's disease on chromosome 21. Lancet 333, 352-355.
45. Goedert, M., Baur, C. P., Ahringer, J., Jakes, R., Hasegawa, M., Spillantini, M. G., Smith, M. J., and Hill, F. (1996). PTL-1, a microtubule-associated protein with tau-like repeats from the nematode Caenorhabditis elegans. J. Cell. Sci. 109(Pt 11), 2661-2672.
46. Goedert, M., Ghetti, B., and Spillantini, M. G. (2012). Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006254.
47. Goedert, M., Hasegawa, M., Jakes, R., Lawler, S., Cuenda, A., and Cohen, P. (1997). Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBSLett. 409, 57-62.
48. Goedert, M., and Spillantini, M. G. (2006). A century of Alzheimer's disease. Science 314, 777-781.
49. Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., and Klug, A. (1988). Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U.S.A. 85, 4051-4055.
50. Gotz, J., Chen, F., Barmettler, R., and Nitsch, R. M. (2001a). Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276, 529-534.
51. Gotz, J., Chen, F., van Dorpe, J., and Nitsch, R. M. (2001b). Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Abeta 42 fibrils. Science 293, 1491-1495.
52. Gotz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D., and Ittner, L. M. (2010). Animal models reveal role for tau phosphorylation in human disease. Biochim. Biophys. Acta 1802, 860-871.
53. Gotz, J., and Gotz, N. N. (2009). Animal models for Alzheimer's disease and frontotemporal dementia: a perspective. ASN Neuro 1, pii: e00019.
54. Gotz, J., Ittner, A., and Ittner, L. M. (2012). Tau-targeted treatment strategies in Alzheimer's disease. Br. J. Pharmacol. 165, 1246-1259.
55. Gotz, J., and Ittner, L. M. (2008). Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 9, 532-544.
56. Gotz, J., Ittner, L. M., Schonrock, N., and Cappai, R. (2008). An update on the toxicity of Abeta in Alzheimer's disease. Neuropsychiatr. Dis. Treat. 4, 1033-1042.
57. Gotz, J., Schonrock, N., Vissel, B., and Ittner, L. M. (2009). Alzheimer's Disease Selective Vulnerability and Modelling in Transgenic Mice. J. Alzheimers Dis. 18, 243-251.
58. Greeve, I., Hermans-Borgmeyer, I., Brellinger, C., Kasper, D., Gomez-Isla, T., Behl, C., Levkau, B., and Nitsch, R. M. (2000). The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J. Neurosci. 20, 7345-7352.
59. Grueninger, F., Bohrmann, B., Christensen, K., Graf, M., Roth, D., and Czech, C. (2011). Novel screening cascade identifies MKK4 as key kinase regulating Tau phosphorylation at Ser422. Mol. Cell. Biochem. 357, 199-207.
60. Grueninger, F., Bohrmann, B., Czech, C., Ballard, T. M., Frey, J. R., Weidensteiner, C., von Kienlin, M., and Ozmen, L. (2010). Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice. Neurobiol. Dis. 37, 294-306.
61. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., and Binder, L. I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83,4913-4917.
62. Hardy, J. (2006). Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J. Alzheimers Dis. 9, 151-153.
63. Hauptmann, S., Scherping, I., Drose, S., Brandt, U., Schulz, K. L., Jendrach, M., Leuner, K., Eckert, A., and Muller, W. E. (2008). Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol. Aging. 30, 1574-1586.
64. Hebert, S. S., Horre, K., Nicolai, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., and De Strooper, B. (2009). MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol. Dis. 33, 422-428.
65. Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., and De Strooper, B. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-6420.
66. Ho, L., Xiang, Z., Mukherjee, P., Zhang, W., De Jesus, N., Mirjany, M., Yemul, S., and Pasinetti, G. M. (2001). Gene expression profiling of the tau mutant (P301L) transgenic mouse brain. Neurosci. Lett. 310, 1-4.
67. Hoerndli, F., David, D., and Gotz, J. (2005). Functional genomics meets neurodegenerative disorders. Part II: application and data integration. Prog. Neurobiol. 76, 169-188.
68. Hoerndli, E J., Toigo, M., Schild, A., Gotz, J., and Day, P. J. (2004). Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction. Anal. Biochem. 335, 30-41.
69. Hoopes, J. T., Liu, X., Xu, X., Demeler, B., Folta-Stogniew, E., Li, C., and Ha, Y. (2010). Structural characterization of the E2 domain of APL-1, a Caenorhabditis elegans homolog of human amyloid precursor protein, and its heparin binding site. J. Biol. Chem. 285,2165-2173.
70. Hornsten, A., Lieberthal, J., Fadia, S., Malins, R., Ha, L., Xu, X., Daigle, I., Markowitz, M., O'Connor, G., Plasterk, R., and Li, C. (2007). APL-1, a Caenorhabditis elegans protein related to the human beta-amyloid precursor protein, is essential for viability. Proc. Natl. Acad. Sci. U.S.A. 104, 1971-1976.
71. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice [see comments]. Science 274, 99-102.
72. Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R. C., Stevens, M., de Graaff, E., Wauters, E., van Baren, J., Hillebrand, M., Joosse, M., Kwon, J. M., Nowotny, P., Che, L. K., Morris, J. C., Reed, L. A., Trojanowski, J., Basun, H., Lannfelt, L., Neystat, M., Fahn, S., Dark, F., Tannenberg, T., Dodd, P. R., Hayward, N., Kwok, J. B., Schofield, P. R., Andreadis, A., Snowden, J., Craufurd, D., Neary, D., Owen, F., Oostra, B. A., Hardy, J., Goate, A., van Swieten, J., Mann, D., Lynch, T., and Heutink, P. (1998). Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
73. Igaz, L. M., Kwong, L. K., Chen-Plotkin, A., Winton, M. J., Unger, T. L., Xu, Y., Neumann, M., Trojanowski, J. Q., and Lee, V. M. (2009). Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem. 284, 8516-8524.
74. Ihara, Y., Nukina, N., Miura, R., and Ogawara, M. (1986). Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. 99, 1807-1810.
75. Ittner, L. M., Fath, T., Ke, Y D., Bi, M., van Eersel, J., Li, K. M., Gunning, P., and Gotz, J. (2008). Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A. 105, 15997-16002.
76. Ittner, L. M., and Gotz, J. (2011). Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65-72.
77. Ittner, L. M., Ke, Y D., Delerue, E, Bi, M., Gladbach, A., van Eersel, J., Wolfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., Eckert, A., Staufenbiel, M., Hardeman, E., and Gotz, J. (2010). Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387-397.
78. Ittner, L. M., Ke, Y D., and Gotz, J. (2009). Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease. J. Biol. Chem. 284,20909-20916.
79. Jucker, M., and Walker, L. C. (2011). Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann. Neurol. 70, 532-540.
80. Kaletta, T., and Hengartner, M. O. (2006). Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5, 387-398.
81. Ke, Y., Dramiga, J., Schutz, U., Kril, J. J., Ittner, L. M., Schroder, H., and Gotz, J. (2012). Tau-mediated nuclear depletion and cyto-plasmic accumulation of SFPQ in Alzheimer's and pick's disease. PLoS ONE 7:e35678. doi: 10.1371/journal.pone.0035678
82. Ke, Y. D., Delerue, F., Gladbach, A., Gotz, J., and Ittner, L. M. (2009). Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS ONE 4:e7917. doi: 10.1371/journal.pone.0007917
83. Khurana, V., Merlo, P., Duboff, B., Fulga, T. A., Sharp, K. A., Campbell, S. D., Gotz, J., and Feany, M. B. (2012). A neuroprotective role for the DNA damage checkpoint in tauopathy. Aging Cell 11, 360-362.
84. Kim, J., Basak, J. M., and Holtzman, D. M. (2009). The role of apolipopro-tein E in Alzheimer's disease. Neuron 63, 287-303.
85. Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G., and Abeliovich, A. (2007). A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224.
86. Kins, S., Kurosinski, P., Nitsch, R. M., and Gotz, J. (2003). Activation of the ERK and JNK signaling pathways caused by neuron specific inhibition of PP2A in transgenic mice. Am. J. Pathol. 163, 833-843.
87. Klein, C., Kramer, E. M., Cardine, A. M., Schraven, B., Brandt, R., and Trotter, J. (2002). Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J. Neurosci. 22, 698-707.
88. Konig, J., Zarnack, K., Luscombe, N. M., and Ule, J. (2011). Protein-RNA interactions: new genomic technologies and perspectives. Nat. Rev. Genet. 13, 77-83.
89. Kopke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., and Grundke-Iqbal, I. (1993). Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J. Biol. Chem. 268,24374-24384.
90. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986). Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83, 4044-4048.
91. Kraemer, B. C., Zhang, B., Leverenz, J. B., Thomas, J. H., Trojanowski, J. Q., and Schellenberg, G. D. (2003). From the cover: neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl. Acad. Sci. U.S.A. 100, 9980-9985.
92. Kurosinski, P., and Gotz, J. (2002). Glial cells under physiologic and pathological conditions. Arch. Neurol. 59, 1524-1528.
93. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., and Fahrenholz, F. (1999). Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metallopro-tease. Proc. Natl. Acad. Sci. U.S.A. 96, 3922-3927.
94. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., Lin, C., Socci, N. D., Hermida, L., Fulci, V., Chiaretti, S., Foa, R., Schliwka, J., Fuchs, U., Novosel, A., Muller, R. U., Schermer, B., Bissels, U., Inman, J., Phan, Q., Chien, M., Weir, D. B., Choksi, R., De Vita, G., Frezzetti, D., Trompeter, H. I., Hornung, V., Teng, G., Hartmann, G., Palkovits, M., Di Lauro, R., Wernet, P., Macino, G., Rogler, C. E., Nagle, J. W., Ju, J., Papavasiliou, F. N., Benzing, T., Lichter, P., Tam, W., Brownstein, M. J., Bosio, A., Borkhardt, A., Russo, J. J., Sander, C., Zavolan, M., and Tuschl, T. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
95. Lau, P., and de Strooper, B. (2010). Dysregulated microRNAs in neurodegenerative disorders. Semin. Cell Dev. Biol. 21,768-773.
96. Levitan, D., and Greenwald, I. (1995). Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354.
97. Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., Eckman, C., Hardy, J., Hutton, M., and McGowan, E. (2001). Enhanced neurofibril-lary degeneration in transgenic mice expressing mutant tau and APP. Science293, 1487-1491.
98. Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, P. M., Baker, M., Yu, X., Duff, K., Hardy, J., Corral, A., Lin, W. L., Yen, S. H., Dickson, D. W., Davies, P., and Hutton, M. (2000). Neurofibrillary tangles, amyotro-phy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405.
99. Li, X., and Greenwald, I. (1997). HOP-1, a Caenorhabditis elegans pre-senilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc. Natl. Acad. Sci. U.S.A. 94, 12204-12209.
100. Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., Kukull, W., Morris, J. C., Hulette, C. M., Schmechel, D., Rogers, J., and Stephan, D. A. (2008). Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc. Natl. Acad. Sci. U.S.A. 105, 4441-4446.
101. Lim, Y. A., Grimm, A., Giese, M., Mensah-Nyagan, A. G., Villafranca, J. E., Ittner, L. M., Eckert, A., and Gotz, J. (2011). Inhibition of the mitochondrial enzyme ABAD restores the amyloid-beta-mediated deregulation of estradiol. PLoS ONE 6:e28887. doi: 10.1371/journal.pone.0028887
102. Link, C. D. (1995). Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 92, 9368-9372.
103. Liscic, R. M., Grinberg, L. T., Zidar, J., Gitcho, M. A., and Cairns, N. J. (2008). ALS and FTLD: two faces of TDP-43 proteinopathy. Eur. J. Neurol. 15, 772-780.
104. Liu, X., Dobbie, M., Tunningley, R., Whittle, B., Zhang, Y., Ittner, L. M., and Gotz, J. (2011). ENU muta-genesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice. J. Biomed. Biotechnol. 2011, 130947.
105. Lockstone, H. E., Harris, L. W., Swatton, J. E., Wayland, M. T., Holland, A. J., and Bahn, S. (2007). Gene expression profiling in the adult Down syndrome brain. Genomics 90, 647-660.
106. Loomis, P. A., Howard, T. H., Castleberry, R. P., and Binder, L. I. (1990). Identification of nuclear tau isoforms in human neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 87, 8422-8426.
107. Lukiw, W J. (2007). Micro-RNA speci-ation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18,297-300.
108. Magnani, E., Fan, J., Gasparini, L., Golding, M., Williams, M., Schiavo, G., Goedert, M., Amos, L. A., and Spillantini, M. G. (2007). Interaction of tau protein with the dynactin complex. EMBO J. 26, 4546-4554.
109. Mahley, R. W., Weisgraber, K. H., and Huang, Y. (2006). Apolipoprotein E4, a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103, 5644-5651.
110. Marazziti, D., Baroni, S., Picchetti, M., Landi, P., Silvestri, S., Vatteroni, E., and Catena Dell'Osso, M. (2012). Psychiatric disorders and mitochondrial dysfunctions. Eur. Rev. Med. Pharmacol. Sci. 16,270-275.
111. Martin, J. A., and Wang, Z. (2011). Next-generation transcriptome assembly. Nat. Rev. Genet. 12, 671-682.
112. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82,4245-4249.
113. Mattick, J. S., and Makunin, I. V. (2005). Small regulatory RNAs in mammals. Hum. Mol. Genet. 14, R121-R132.
114. Matus, A. (1990). Microtubule-associated proteins and the determination of neuronal form. J. Physiol. (Paris) 84, 134-137.
115. McDermott, J. B., Aamodt, S., and Aamodt, E. (1996). ptl-1, a Caenorhabditis elegans gene whose products are homologous to the tau microtubule-associated proteins. Biochemistry 35, 9415-9423.
116. Mioshi, E., Hsieh, S., Savage, S., Hornberger, M., and Hodges, J. R. (2010). Clinical staging and disease progression in frontotemporal dementia. Neurology 74,1591-1597.
117. Miyasaka, T., Ding, Z., Gengyo-Ando, K., Oue, M., Yamaguchi, H., Mitani, S., and Ihara, Y. (2005). Progressive neurodegeneration in C. elegans model of tauopathy. Neurobiol. Dis. 20, 372-383.
118. Morcos, M., and Hutter, H. (2009). The model Caenorhabditis elegans in diabetes mellitus and Alzheimer's disease. J. Alzheimers Dis. 16, 897-908.
119. Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L. (2000). High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synapto-toxicity without plaque formation. J. Neurosci. 20, 4050-4058.
120. Murrell, J., Farlow, M., Ghetti, B., and Benson, M. D. (1991). A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99.
121. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., McCluskey, L. F., Miller, B. L., Masliah, E., Mackenzie, I. R., Feldman, H., Feiden, W., Kretzschmar, H. A., Trojanowski, J. Q., and Lee, V. M. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.
122. Neumann, M., Schulz-Schaeffer, W., Crowther, R. A., Smith, M. J., Spillantini, M. G., Goedert, M., and Kretzschmar, H. A. (2001). Pick's disease associated with the novel tau gene mutation K369I. Ann. Neurol. 50,503-513.
123. Nickerson, D. A., Taylor, S. L., Fullerton, S. M., Weiss, K. M., Clark, A. G., Stengard, J. H., Salomaa, V., Boerwinkle, E., and Sing, C. F. (2000). Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res. 10, 1532-1545.
124. Nunez-Iglesias, J., Liu, C. C., Morgan, T. E., Finch, C. E., and Zhou, X. J. (2010). Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS ONE 5:e8898. doi: 10.1371/ journal.pone.0008898
125. Papasozomenos, S. C., and Su, Y. (1991). Altered phosphorylation of tau protein in heat-shocked rats and patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 88, 4543-4547.
126. Pasinetti, G. M. (2001). Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J. Neurosci. Res. 65, 471-476.
127. Pasinetti, G. M., and Ho, L. (2001). From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia. Restor. Neurol. Neurosci. 18, 137-142.
128. Pasquinelli, A. E., Reinhart, B. J., Slack, F., Martindale, M. Q., Kuroda, M. I., Maller, B., Hayward, D. C., Ball, E. E., Degnan, B., Muller, P., Spring, J., Srinivasan, A., Fishman, M., Finnerty, J., Corbo, J., Levine, M., Leahy, P., Davidson, E., and Ruvkun, G. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86-89.
129. Patel, V. P., and Chu, C. T. (2011). Nuclear transport, oxidative stress, and neurodegeneration. Int. J. Clin. Exp.Pathol. 4,215-229.
130. Pennanen, L., and Gotz, J. (2005). Different tau epitopes define Abeta(42)-mediated tau insolubility. Biochem. Biophys. Res. Commun. 337, 1097-1101.
131. Pennanen, L., Welzl, H., D'Adamo, P., Nitsch, R. M., and Gotz, J. (2004). Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice. Neurobiol Dis. 15, 500-509.
132. Pennanen, L., Wolfer, D. P., Nitsch, R. M., and Gotz, J. (2006). Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice. Genes Brain Behav. 5, 369-379.
133. Pettegrew, J. W., Withers, G., Panchalingam, K., and Post, J. F. (1987). 31P nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer's disease. J. Neural Transm. Suppl. 24, 261-268.
134. Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W C, Raskind, M., and Schellenberg, G. D. (1998). Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815-825.
135. Ramskold, D., Kavak, E., and Sandberg, R. (2012). How to analyze gene expression using RNA-sequencing data. Methods Mol. Biol. 802, 259-274.
136. Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., and Ferreira, A. (2002). Tau is essential to beta -amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 99, 6364-6369.
137. Reis-Rodrigues, P., Czerwieniec, G., Peters, T. W., Evani, U. S., Alavez, S., Gaman, E. A., Vantipalli, M., Mooney, S. D., Gibson, B. W., Lithgow, G. J., and Hughes, R. E. (2012). Proteomic analysis of age-dependent changes in protein solubility identifies genes that modulate lifespan. Aging Cell 11, 120-127.
138. Rhein, V., Song, X., Wiesner, A., Ittner, L. M., Baysang, G., Meier, F., Ozmen, L., Bluethmann, H., Drose, S., Brandt, U., Savaskan, E., Czech, C., Gotz, J., and Eckert, A. (2009). Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc. Natl. Acad. Sci. U.S.A. 106, 20057-20062.
139. Roberson, E. D., and Mucke, L. (2006). 100 years and counting: prospects for defeating Alzheimer's disease. Science 314, 781-784.
140. Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G. Q., and Mucke, L. (2007). Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
141. Roses, A. D. (1996). Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med. 47, 387-400.
142. Saito, T., Suemoto, T., Brouwers, N., Sleegers, K., Funamoto, S., Mihira, N., Matsuba, Y., Yamada, K., Nilsson, P., Takano, J., Nishimura, M., Iwata, N., Van Broeckhoven, C., Ihara, Y., and Saido, T. C. (2011). Potent amyloidogenicity and pathogenicity of Abeta43. Nat. Neurosci. 14, 1023-1032.
143. Sandberg, R., Yasuda, R., Pankratz, D. G., Carter, T. A., Del Rio, J. A., Wodicka, L., Mayford, M., Lockhart, D. J., and Barlow, C. (2000). Regional and strain-specific gene expression mapping in the adult mouse brain. Proc. Natl. Acad. Sci. U.S.A. 97, 11038-11043.
144. Schon, E. A., and Przedborski, S. (2011). Mitochondria: the next (neurode)generation. Neuron 70, 1033-1053.
145. Schonrock, N., Ke, Y D., Humphreys, D., Staufenbiel, M., Ittner, L. M., Preiss, T., and Gotz, J. (2010). Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS ONE 5:e11070. doi: 10.1371/journal.pone.0011070
146. Schonrock, N., Matamales, M., Ittner, L. M., and Gotz, J. (2011). MicroRNA networks surround ing APP and amyloid-beta metabolism-Implications for Alzheimer's disease. Exp. Neurol. 235, 447-454.
147. Shioya, M., Obayashi, S., Tabunoki, H., Arima, K., Saito, Y., Ishida, T., and Satoh, J. (2010). Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 36, 320-330.
148. Shulman, J. M., and Feany, M. B. (2003). Genetic modifiers of tauopathy in Drosophila. Genetics 165,1233-1242.
149. Siomi, H., and Siomi, M. C. (2010). Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 38, 323-332.
150. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S., and Mumby, M. C. (1996). Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 17, 1201-1207.
151. Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., and Ghetti, B. (1998). Mutation in the tau gene in familial multiple system tauopathy with prese-nile dementia. Proc. Natl. Acad. Sci. U.S.A. 95,7737-7741.
152. Steinhilb, M. L., Dias-Santagata, D., Fulga, T. A., Felch, D. L., and Feany, M. B. (2007). Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol. Biol. Cell 18, 5060-5068.
153. St George-Hyslop, P. H., Haines, J. L., Farrer, L. A., Polinsky, R., Van Broeckhoven, C., Goate, A., McLachlan, D. R., Orr, H., Bruni, A. C., Sorbi, S., Rainero, I., Foncin, J. F, Pollen, D., Cantu, J. M., Tupler, R., Voskresenskaya, N., Mayeux, R., Growden, J., Fried, V A., Myers, R. H., Nee, L., Backhovens, H., Martin, J. J., Rossor, M., Owen, M. J., Mullan, M., Percy, M. E., Karlinsky, H., Rich, S., Heston, L., Montesi, M., Mortilla, M., Nacmias, N., Gusella, J. F., and Hardy, J. A. (1990). Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature 347, 194-197.
154. Stoothoff, W., Jones, P. B., Spires-Jones, T. L., Joyner, D., Chhabra, E., Bercury, K., Fan, Z., Xie, H., Bacskai, B., Edd, J., Irimia, D., and Hyman, B. T. (2009). Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport. J. Neurochem. 111, 417-427.
155. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P. A., Waridel, C., Calhoun, M. E., Jucker, M., Probst, A., Staufenbiel, M., and Sommer, B. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94, 13287-13292.
156. Takeda, S., Sato, N., Uchio-Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H., and Morishita, R. (2010). Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. U.S.A. 107, 7036-7041
157. Urwin, H., Josephs, K. A., Rohrer, J. D., Mackenzie, I. R., Neumann, M., Authier, A., Seelaar, H., Van Swieten, J. C., Brown, J. M., Johannsen, P., Nielsen, J. E., Holm, I. E., Dickson, D. W., Rademakers, R., Graff-Radford, N. R., Parisi, J. E., Petersen, R. C., Hatanpaa, K. J., White, C. L. 3rd., Weiner, M. F., Geser, F., Van Deerlin, V. M., Trojanowski, J. Q., Miller, B. L., Seeley, W. W., van der Zee, J., Kumar-Singh, S., Engelborghs, S., De Deyn, P. P., Van Broeckhoven, C., Bigio, E. H., Deng, H. X., Halliday, G. M., Kril, J. J., Munoz,D.G., Mann, D. M., Pickering-Brown, S. M., Doodeman, V., Adamson, G., Ghazi-Noori, S., Fisher, E. M., Holton, J. L., Revesz, T., Rossor, M. N., Collinge, J., Mead, S., and Isaacs, A. M. (2010). FUS pathology defines the majority of tau- and TDP-43-negative fron-totemporal lobar degeneration. Acta Neuropathol. 120,33-41.
158. Van Dam, D., D'Hooge, R., Staufenbiel, M., Van Ginneken, C., Van Meir, E, and De Deyn, P. P. (2003). Age-dependent cognitive decline in the APP23 model precedes amy loid deposition. Eur. J. Neurosci. 17, 388-396.
159. van de Hoef, D. L., Hughes, J., Livne-Bar, I., Garza, D., Konsolaki, M., and Boulianne, G. L. (2009). Identifying genes that interact with Drosophila presenilin and amyloid precursor protein. Genesis 47, 246-260.
160. van Eersel, J., Ke, Y. D., Liu, X., Delerue, F., Kril, J. J., Gotz, J., and Ittner, L. M. (2010). Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc. Natl. Acad. Sci. U.S.A. 107, 13888-13893.
161. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M. (1999). Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspar-tic protease BACE. Science 286, 735-741.
162. Velculescu, V E., Zhang, L., Vogelstein, B., and Kinzler, K. W. (1995). Serial analysis of gene expression. Science 270, 484-487.
163. Wang, H., Liu, J., Zong, Y., Xu, Y., Deng, W., Zhu, H., Liu, Y., Ma, C., Huang, L., Zhang, L., and Qin, C. (2010). miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res. 1357, 166-174.
164. Wang, W X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., and Nelson, P. T. (2008). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 1213-1223.
165. Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., and Kirschner, M. W. (1975). A protein factor essential for microtubule assembly. Proc. Natl Acad. Sci. U.S.A. 72, 1858-1862.
166. Wiese, M., Antebi, A., and Zheng, H. (2010). Intracellular trafficking and synaptic function of APL-1 in Caenorhabditis elegans. PLoS ONE 5:e12790. doi: 10.1371/ journal.pone.0012790
167. Williams, A. H., Valdez, G., Moresi, V., Qi, X., McAnally, J., Elliott, J. L., Bassel-Duby, R., Sanes, J. R., and Olson, E. N. (2009). MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscu-lar synapses in mice. Science 326, 1549-1554.
168. Wischik, C. M., Novak, M., Thogersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., and Klug, A. (1988). Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 85,4506-4510.
169. Xu, Y., Chen, Y., Zhang, P., Jeffrey, P. D., and Shi, Y (2008). Structure of a protein phosphatase 2A holoen-zyme: insights into B55-mediated tau dephosphorylation. Mol. Cell 31,873-885.
170. Yao, J., Taylor, M., Davey, F., Ren, Y., Aiton, J., Coote, P., Fang, F., Chen, J. X., Yan, S. D., and Gunn-Moore, F. J. (2007). Interaction of amyloid binding alcohol dehydroge-nase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model. Mol. Cell. Neurosci. 35, 377-382.
171. Zhang, Y J., Xu, Y E, Dickey, C. A., Buratti, E., Baralle, F., Bailey, R., Pickering-Brown, S., Dickson, D., and Petrucelli, L. (2007). Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27, 10530-10534.
172. Zhao, X., Lein, E. S., He, A., Smith, S. C., Aston, C., and Gage, F. H. (2001). Transcriptional profiling reveals strict boundaries between hippocampal subregions. J. Comp. Neurol. 441, 187-196.
173. Zirlinger, M., Kreiman, G., and Anderson, D. J. (2001). Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei. Proc. Natl. Acad. Sci. U.S.A. 98, 5270-5275.
174. Zong, Y., Wang, H., Dong, W., Quan, X., Zhu, H., Xu, Y., Huang, L., Ma, C., and Qin, C. (2011). miR-29c regulates BACE1 protein expression. Brain Res. 1395, 108-115.
175. Zovoilis, A., Agbemenyah, H. Y., Agis-Balboa, R. C., Stilling, R. M., Edbauer, D., Rao, P., Farinelli, L., Delalle, I., Schmitt, A., Falkai, P., Bahari-Javan, S., Burkhardt, S., Sananbenesi, F., and Fischer, A. (2011). microRNA-34c is a novel target to treat dementias. EMBO J. 30, 4299-4308.